BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Prothena Reports First Quarter 2026 Financial Results and Business Highlights

  May 8, 2026

   · 

  14 min read
• Press Releases

  Natera Reports First Quarter 2026 Financial Results

  May 8, 2026

   · 

  12 min read
• Press Releases

  Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights

  May 8, 2026

   · 

  10 min read
• Press Releases

  McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

  May 8, 2026

   · 

  1 min read
• Press Releases

  IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

  May 8, 2026

   · 

  2 min read
• Press Releases

  Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering

  May 8, 2026

   · 

  4 min read
• Press Releases

  Travere Therapeutics to Participate at Upcoming Investor Conferences - May 7, 2026

  May 8, 2026

   · 

  1 min read
• Press Releases

  Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 7, 2026

  May 8, 2026

   · 

  2 min read
• Press Releases

  Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences

  May 8, 2026

   · 

  1 min read
• Press Releases

  Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease

  May 8, 2026

   · 

  18 min read